This week we look at a paper published by the U.S. Food and Drug Administration related to artificial intelligence. We also highlight a statement from the World Health Organization declaring that mpox is no longer a global health emergency, a venture fund focused on blood-related research, and an effort ... READ MORE >
decentralized clinical trials
5 things to know in life sciences: Week of Aug. 1, 2022
This week we highlight how big pharma is grappling with potential challenges surrounding drug pricing and the Inflation Reduction Act of 2022. We also look at Labcorp’s proposed spinoff of its clinical development business, progress toward the $100 genome, the return on investment of decentralized ... READ MORE >
5 things to know in life sciences: Week of July 18, 2022
This week we highlight continued investment in driving more diversity and better representation in clinical trials. We also look at the impact of decentralized technology on trial enrollments, a major whistleblower settlement and the approval of a COVID-19 vaccine manufactured using traditional methods. ... READ MORE >